Patent expiry and biosimilars: difference between revisions
Diff·revision 13 → 14·12:41, 20 Jun 2025
Difference between revision 13 and revision 14 of Patent expiry and biosimilars. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 13 — 04:42, 25 May 2025 FiveOhThreeB (talk) clarify that a business licence is not a manufacturing authorisation 3,580 bytes ±0 | Revision 14 — 12:41, 20 Jun 2025 Chromatokid (talk) clarify the difference between a marketing authorisation and a registration 3,580 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |